Internal Medicine, Hematology · West Hollywood, CA
NPI
1659547487
Since 2008
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8700 Beverly Blvd # Ac1046
West Hollywood, CA, 90048
Phone (310) 423-1160
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
790 services
Medicare patients, 2024
153
Average age 72
Drug cost, 2024
$2.0M
445 prescriptions
Company payments, 2025
$6,755
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Noah M Merin was code 99233 (hospital e&m - subsequent), 236 times for 72 patients. In total Noah M Merin billed 790 services in 14 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 236 | 72 | $99.86 | $24K |
| 99232 Hospital E&M - Subsequent | Facility | 209 | 67 | $67.04 | $14K |
| 99215 Office E&M - Established | Facility | 124 | 35 | $115.25 | $14K |
| 99214 Office E&M - Established | Facility | 75 | 45 | $71.00 | $5,325 |
| 99223 Hospital E&M - Initial | Facility | 53 | 50 | $147.61 | $7,823 |
| 99239 Hospital Discharge Management | Facility | 44 | 40 | $98.49 | $4,333 |
| 99497 Care Management/Coordination | Facility | 16 | 11 | $64.83 | $1,037 |
| 99205 Office E&M - New | Facility | 11 | 11 | $145.12 | $1,596 |
By year: 2022 $51K for 575 services; 2023 $47K for 511 services; 2024 $73K for 790 services.
Medicare prescription drug claims, 2024
In 2024, the drug Noah M Merin prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 41 prescriptions and refills. In total Noah M Merin wrote 445 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 41 | 72 | 16 | $2,083 |
| Sprycel Dasatinib | 36 | 36 | Under 11 | $404K |
| Iclusig Ponatinib Hcl | 36 | 36 | Under 11 | $684K |
| Voriconazole Generic | 27 | 29 | Under 11 | $13K |
| Acyclovir Generic | 25 | 43 | 11 | $483 |
| Levofloxacin Generic | 25 | 26 | 12 | $400 |
| Jakafi Ruxolitinib Phosphate | 18 | 18 | Under 11 | $308K |
| Venclexta Venetoclax | 17 | 17 | Under 11 | $23K |
| Imbruvica Ibrutinib | 12 | 12 | Under 11 | $102K |
| Rezurock Belumosudil Mesylate | 12 | 12 | Under 11 | $217K |
| Prednisone Generic | 11 | 12 | Under 11 | $55.22 |
Brand drugs: - claims; generic drugs: 267 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Noah M Merin $6,755 ($6,755 in general payments such as food, travel and fees) from 10 companies. The largest payer was Stemline Therapeutics Inc. with $2,170.
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 1 | $2,170 |
| Incyte Corporation INCY | 3 | $2,103 |
| Amgen Inc. AMGN | 1 | $1,372 |
| Janssen Biotech, Inc. JNJ | 4 | $309 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $231 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $191 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $136 |
| Pfizer Inc. PFE | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.